About Us Strategy & Mission Our Values Our People Our Board Our Scientific Advisors Our Collaborations Contact Our Programs Pipeline C. difficile Infection Enterobacteriaceae Clinical Trials Our Science Discuva Platform Scientific Literature & Publications Investors Investor Center Press Releases Announcements, Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Shareholder Meetings Careers
Press Releases Our latest press releases are available to read in this section Press Releases Date Range Explore Search Press Releases / 05 May 2021 Summit Therapeutics’ Rights Offering Nearing Expiration Date; Robert W. Duggan Declares Intention to Fully Oversubscribe in the Rights Offering Press Releases / 21 Apr 2021 Summit Therapeutics Announces Commencement of Rights Offering Press Releases / 26 Mar 2021 Summit Therapeutics Announces Rights Offering Press Releases / 17 Mar 2021 Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2020 Press Releases / 23 Nov 2020 Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer Press Releases / 16 Nov 2020 Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020 Press Releases / 06 Nov 2020 Summit Announces Closing of Private Placement of $50 Million Press Releases / 05 Oct 2020 Summit Announces Agreement For a Fundraising of approximately $50 Million Press Releases / 29 Sep 2020 Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020 Press Releases / 18 Sep 2020 Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USA Press Releases / 17 Sep 2020 Summit Therapeutics Announces U.K. Court Approval of Scheme; Expects to Complete Redomiciliation to Delaware, USA as of September 18, 2020 Press Releases / 19 Aug 2020 Summit Announces Results of Court Meeting and General Meeting << 1 2 3 … 29 30 >>
Press Releases / 05 May 2021 Summit Therapeutics’ Rights Offering Nearing Expiration Date; Robert W. Duggan Declares Intention to Fully Oversubscribe in the Rights Offering Press Releases / 21 Apr 2021 Summit Therapeutics Announces Commencement of Rights Offering Press Releases / 26 Mar 2021 Summit Therapeutics Announces Rights Offering Press Releases / 17 Mar 2021 Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2020 Press Releases / 23 Nov 2020 Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer Press Releases / 16 Nov 2020 Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020 Press Releases / 06 Nov 2020 Summit Announces Closing of Private Placement of $50 Million Press Releases / 05 Oct 2020 Summit Announces Agreement For a Fundraising of approximately $50 Million Press Releases / 29 Sep 2020 Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020 Press Releases / 18 Sep 2020 Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USA Press Releases / 17 Sep 2020 Summit Therapeutics Announces U.K. Court Approval of Scheme; Expects to Complete Redomiciliation to Delaware, USA as of September 18, 2020 Press Releases / 19 Aug 2020 Summit Announces Results of Court Meeting and General Meeting
Press Releases / 05 May 2021 Summit Therapeutics’ Rights Offering Nearing Expiration Date; Robert W. Duggan Declares Intention to Fully Oversubscribe in the Rights Offering
Press Releases / 17 Mar 2021 Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2020
Press Releases / 23 Nov 2020 Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer
Press Releases / 16 Nov 2020 Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020
Press Releases / 05 Oct 2020 Summit Announces Agreement For a Fundraising of approximately $50 Million
Press Releases / 29 Sep 2020 Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020
Press Releases / 18 Sep 2020 Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USA
Press Releases / 17 Sep 2020 Summit Therapeutics Announces U.K. Court Approval of Scheme; Expects to Complete Redomiciliation to Delaware, USA as of September 18, 2020
